BNP Paribas Financial Markets’s ACELYRIN SLRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-5,061
Closed -$12.5K 5639
2025
Q1
$12.5K Sell
5,061
-70,053
-93% -$167K ﹤0.01% 4662
2024
Q4
$236K Buy
+75,114
New +$364K ﹤0.01% 3770

Other funds holding SLRN

BNP Paribas Financial Markets's SLRN Position: Q2 2025 in Review

BNP Paribas Financial Markets sold out of ACELYRIN (SLRN) in Q2 2025, closing a stake of 5,061 shares — an estimated $12.5K sold.

BNP Paribas Financial Markets first reported a position in SLRN in Q4 2024 and held it in 2 quarters. The position peaked at $236K in Q4 2024. 2 funds tracked by Wall St. Rank hold SLRN as of Q2 2025.

  • BNP Paribas Financial Markets reported no remaining ACELYRIN position as of Q2 2025 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 5,061 ACELYRIN shares in Q2 2025, an estimated $12.5K.
  • BNP Paribas Financial Markets first reported a position in ACELYRIN in Q4 2024 and held it in 2 quarters.
  • BNP Paribas Financial Markets's ACELYRIN position peaked at $236K in Q4 2024.
  • 2 funds tracked by Wall St. Rank held ACELYRIN as of Q2 2025.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2025, filed 14 Aug 2025.